Order Total (1 Item Items):
Shipping Destination:
Miles Hacker (42 results)
Feedback
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (42)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition
Binding
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (12)
- Not Print on Demand (32)
Language (1)
Free Shipping
Seller Location
Seller Rating
-
The Toxicity of Anticancer Drugs
Published by Pergamon Press, 1991, 1991
ISBN 10: 0080403026 ISBN 13: 9780080403021
Language: English
Hardcover. Condition: Fine. hardback in near fine condition.
-
The Toxicity of anticancer drugs
Published by Pergamon Press, 1991, 1991
ISBN 10: 0080403026 ISBN 13: 9780080403021
Language: English
Seller: Wonder Book, Frederick, MD, U.S.A.
Seller rating 5 out of 5 stars
Condition: Good. Good condition. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains.
-
US$ 8.30
Convert currencyUS$ 27.19 shipping from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,2050grams, ISBN:9780123695215.
-
US$ 59.54
Convert currencyUS$ 3.99 shipping within U.S.A.Quantity: Over 20 available
Add to basketCondition: New.
-
Condition: Used.
-
US$ 63.76
Convert currencyUS$ 8.77 shipping from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: Used.
-
US$ 68.71
Convert currencyUS$ 11.32 shipping from Germany to U.S.A.Quantity: 1 available
Add to basketCondition: Used.
-
Platinum Coordination Complexes in Cancer Chemotherapy: Proceedings of the Fourth International Symposium on Platinum Coordination Complexes in Cancer ... June 22-24, 1983 (Developments in Oncology)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 70.66
Convert currencyUS$ 16.17 shipping from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Pharmacology
Published by Academic Press 2009-10-12, 2009
ISBN 10: 012369521X ISBN 13: 9780123695215
Language: English
US$ 81.90
Convert currencyUS$ 20.91 shipping from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketHardback. Condition: New.
-
US$ 92.34
Convert currencyUS$ 8.77 shipping from United Kingdom to U.S.A.Quantity: 3 available
Add to basketCondition: New. pp. xi + 594 Illus.
-
US$ 70.28
Convert currencyUS$ 35.28 shipping from Germany to U.S.A.Quantity: 1 available
Add to basketTaschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The idea for convening a Fourth International Symposium on Platinum Coordination Complexes in Cancer Chemotherapy was born in an assembly of researchers from the Vermont Regional Cancer Center and the Norris Cotton Cancer Center who shared a common interest in metal complexes. It was agreed by those assembled that sufficient time had passed since the Third International Symposium on Platinum Coor dination Complexes in Cancer Chemotherapy held in 1976 at the Wadley Institutes of Molecular Medicine in Dallas, Texas, during which several advances in the chemistry, biochemistry, pharmacology and clinical use of platinum complexes had occurred, to warrant a fourth symposium. Furthermore, intensive investigations in progress were bringing sophisticated methodologies to bear on the problems in the field, clinical trials were yielding interesting results, and unique approaches to cancer therapy were being designed. Therefore, an organizing committee was formed and planning culminated in the symposium which was held in Burlington, Vermont, June 22-24, 1983.
-
US$ 97.60
Convert currencyUS$ 13.50 shipping from United Kingdom to U.S.A.Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 1st edition. 608 pages. 11.00x8.50x1.25 inches. In Stock.
-
US$ 103.22
Convert currencyUS$ 11.32 shipping from Germany to U.S.A.Quantity: 4 available
Add to basketCondition: New.
-
US$ 99.64
Convert currencyUS$ 20.91 shipping from United Kingdom to U.S.A.Quantity: 10 available
Add to basketPF. Condition: New.
-
Condition: New. pp. xi + 594 1st Edition.
-
US$ 123.19
Convert currencyUS$ 11.32 shipping from Germany to U.S.A.Quantity: 3 available
Add to basketCondition: New. pp. xi + 594.
-
Condition: New. pp. 272.
-
US$ 131.97
Convert currencyUS$ 8.77 shipping from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: New. pp. 272 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.
-
US$ 142.69
Convert currencyUS$ 11.32 shipping from Germany to U.S.A.Quantity: 1 available
Add to basketCondition: New. pp. 272.
-
US$ 123.75
Convert currencyUS$ 33.75 shipping from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback. Condition: Like New. Like New. book.
-
Platinum Coordination Complexes in Cancer Chemotherapy
Published by Springer US, Springer New York Nov 2011, 2011
ISBN 10: 1461297923 ISBN 13: 9781461297925
Language: English
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
US$ 100.25
Convert currencyUS$ 62.57 shipping from Germany to U.S.A.Quantity: 2 available
Add to basketTaschenbuch. Condition: Neu. Neuware -The idea for convening a Fourth International Symposium on Platinum Coordination Complexes in Cancer Chemotherapy was born in an assembly of researchers from the Vermont Regional Cancer Center and the Norris Cotton Cancer Center who shared a common interest in metal complexes. It was agreed by those assembled that sufficient time had passed since the Third International Symposium on Platinum Coor dination Complexes in Cancer Chemotherapy held in 1976 at the Wadley Institutes of Molecular Medicine in Dallas, Texas, during which several advances in the chemistry, biochemistry, pharmacology and clinical use of platinum complexes had occurred, to warrant a fourth symposium. Furthermore, intensive investigations in progress were bringing sophisticated methodologies to bear on the problems in the field, clinical trials were yielding interesting results, and unique approaches to cancer therapy were being designed. Therefore, an organizing committee was formed and planning culminated in the symposium which was held in Burlington, Vermont, June 22-24, 1983.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 400 pp. Englisch.
-
US$ 178.51
Convert currencyUS$ 3.99 shipping within U.S.A.Quantity: Over 20 available
Add to basketCondition: New.
-
Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4-6, 1987 (Developments in Oncology, 53)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 193.59
Convert currencyUS$ 16.17 shipping from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... USA-June 4-6, 1987 (Developments in Oncology)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 193.59
Convert currencyUS$ 16.17 shipping from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Organ Directed Toxicities of Anticancer Drugs : Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer Drugs Burlington, Vermont, USA-June 4-6, 1987
Published by Springer US, Springer New York, 2011
ISBN 10: 1461292050 ISBN 13: 9781461292050
Language: English
US$ 195.86
Convert currencyUS$ 34.22 shipping from Germany to U.S.A.Quantity: 1 available
Add to basketTaschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected human malignancies. Due to a general inability to dif ferentiate between normal and neoplastic cells, little selectivity exists in currently used oncolytic drugs. Consequently, significant toxicity to the patient is expected when systemic cancer chemotherapy is chosen as an appropriate therapeutic in tervention. Much of this toxicity, such as damage to the bone marrow, gastroin testinal tract, or hair follicles, is predictable based upon the fact that anticancer drugs kill actively dividing cells. These types of toxicities, while serious, are usually manageable and reversible and are, therefore, not often considered to be dose limiting. Unfortunately, several of the most important anticancer drugs also damage tissues in which the growth fraction is relatively small. Such toxicities can not be predicted based on the chemical structure of the drugs, are often not detected in preclinical studies, and are encountered frequently for the first time in clinical studies. Further, unlike most of the proliferative-dependent toxicities, the unpre dicted toxicities are usually irreversible or only partially reversible upon cessation of drug administration. Because of this, the unpredicted toxicities are referred to as dose limiting. They represent a significant barrier to the ultimate efficacy of several of our most important anticancer drugs.
-
Organ Directed Toxicities of Anticancer Drugs : Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer Drugs Burlington, Vermont, USA-June 4-6, 1987
Published by Springer US, Springer US, 1988
ISBN 10: 0898383560 ISBN 13: 9780898383560
Language: English
US$ 197.72
Convert currencyUS$ 35.11 shipping from Germany to U.S.A.Quantity: 1 available
Add to basketBuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected human malignancies. Due to a general inability to dif ferentiate between normal and neoplastic cells, little selectivity exists in currently used oncolytic drugs. Consequently, significant toxicity to the patient is expected when systemic cancer chemotherapy is chosen as an appropriate therapeutic in tervention. Much of this toxicity, such as damage to the bone marrow, gastroin testinal tract, or hair follicles, is predictable based upon the fact that anticancer drugs kill actively dividing cells. These types of toxicities, while serious, are usually manageable and reversible and are, therefore, not often considered to be dose limiting. Unfortunately, several of the most important anticancer drugs also damage tissues in which the growth fraction is relatively small. Such toxicities can not be predicted based on the chemical structure of the drugs, are often not detected in preclinical studies, and are encountered frequently for the first time in clinical studies. Further, unlike most of the proliferative-dependent toxicities, the unpre dicted toxicities are usually irreversible or only partially reversible upon cessation of drug administration. Because of this, the unpredicted toxicities are referred to as dose limiting. They represent a significant barrier to the ultimate efficacy of several of our most important anticancer drugs.
-
Organ Directed Toxicities of Anticancer Drugs
Published by Springer US, Springer US Jan 1988, 1988
ISBN 10: 0898383560 ISBN 13: 9780898383560
Language: English
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
US$ 188.06
Convert currencyUS$ 62.57 shipping from Germany to U.S.A.Quantity: 2 available
Add to basketBuch. Condition: Neu. Neuware -The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected human malignancies. Due to a general inability to dif ferentiate between normal and neoplastic cells, little selectivity exists in currently used oncolytic drugs. Consequently, significant toxicity to the patient is expected when systemic cancer chemotherapy is chosen as an appropriate therapeutic in tervention. Much of this toxicity, such as damage to the bone marrow, gastroin testinal tract, or hair follicles, is predictable based upon the fact that anticancer drugs kill actively dividing cells. These types of toxicities, while serious, are usually manageable and reversible and are, therefore, not often considered to be dose limiting. Unfortunately, several of the most important anticancer drugs also damage tissues in which the growth fraction is relatively small. Such toxicities can not be predicted based on the chemical structure of the drugs, are often not detected in preclinical studies, and are encountered frequently for the first time in clinical studies. Further, unlike most of the proliferative-dependent toxicities, the unpre dicted toxicities are usually irreversible or only partially reversible upon cessation of drug administration. Because of this, the unpredicted toxicities are referred to as dose limiting. They represent a significant barrier to the ultimate efficacy of several of our most important anticancer drugs.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 270 pp. Englisch.
-
US$ 208.75
Convert currencyUS$ 55.74 shipping from Germany to U.S.A.Quantity: Over 20 available
Add to basketGebunden. Condition: New. Proceedings of the First International Symposium on the Organ Directed Toxicities of Anticancer Drugs convened at Burlington, VT, June 4-6, 1987. The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected.
-
Condition: New. pp. 272.
-
Organ Directed Toxicities of Anticancer Drugs
Published by Springer US, Springer New York Nov 2011, 2011
ISBN 10: 1461292050 ISBN 13: 9781461292050
Language: English
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
US$ 244.45
Convert currencyUS$ 62.57 shipping from Germany to U.S.A.Quantity: 2 available
Add to basketTaschenbuch. Condition: Neu. Neuware -The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected human malignancies. Due to a general inability to dif ferentiate between normal and neoplastic cells, little selectivity exists in currently used oncolytic drugs. Consequently, significant toxicity to the patient is expected when systemic cancer chemotherapy is chosen as an appropriate therapeutic in tervention. Much of this toxicity, such as damage to the bone marrow, gastroin testinal tract, or hair follicles, is predictable based upon the fact that anticancer drugs kill actively dividing cells. These types of toxicities, while serious, are usually manageable and reversible and are, therefore, not often considered to be dose limiting. Unfortunately, several of the most important anticancer drugs also damage tissues in which the growth fraction is relatively small. Such toxicities can not be predicted based on the chemical structure of the drugs, are often not detected in preclinical studies, and are encountered frequently for the first time in clinical studies. Further, unlike most of the proliferative-dependent toxicities, the unpre dicted toxicities are usually irreversible or only partially reversible upon cessation of drug administration. Because of this, the unpredicted toxicities are referred to as dose limiting. They represent a significant barrier to the ultimate efficacy of several of our most important anticancer drugs.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 272 pp. Englisch.
